 GAITHERSBURG, Md. and HOLZGERLINGEN, Germany, Jan. 05, 2021 GLOBE NEWSWIRE -- OpGen, Inc. Nasdaq: OPGN, OpGen, a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has entered into a distribution agreement with Annar Health Technologies Annar for Colombia. Annar, headquartered in Bogotá, is Colombias leading diagnostics distributor that is already working with numerous renowned global IVD manufacturers. 